Filtered By:
Vaccination: Influenza Vaccine
Countries: India Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 37 results found since Jan 2013.
U.S. Will Lift Most Federal COVID-19 Vaccine Mandates Next Week
WASHINGTON — The Biden administration will end most of the last remaining federal COVID-19 vaccine requirements next week when the national public health emergency for the coronavirus ends, the White House said Monday.
Vaccine requirements for federal workers and federal contractors, as well as foreign air travelers to the U.S., will end May 11. The government is also beginning the process of lifting shot requirements for Head Start educators, healthcare workers, and noncitizens at U.S. land borders.
The requirements are among the last vestiges of some of the more coercive measures taken by the federal government to ...
Source: TIME: Health - May 2, 2023 Category: Consumer Health News Authors: Zeke Miller/AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Why the U.S. Doesn ’t Have a Nasal Vaccine for COVID-19
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection. In order to put the pandemic behind us, the world will need a way to stop infections and spread of the virus. That’s where a different type of vaccine, one that works at the places where the virus gets into the body, will likely prove useful.
Here, though, the U.S. is losing its edge. In September, India approved a nasal COVID-19 vacc...
Source: TIME: Health - October 31, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
IJERPH, Vol. 19, Pages 14074: Mortality Risk Factors for Coronavirus Infection in Hospitalized Adults in Brazil: A Retrospective Cohort Study
Conclusions: Our results illustrate the severity of the COVID-19 pandemic in Brazil and reinforce that policies and practices to deal with this disease should focus on groups and regions with higher risk, whereas public policies should promote nonpharmacological measures and vaccination in the Brazilian population.
Source: International Journal of Environmental Research and Public Health - October 28, 2022 Category: Environmental Health Authors: Rafael Alves Guimar ães Raquel Silva Pinheiro Hellen da Silva Cintra de Paula Lyriane Apolin ário de Araújo Ingrid Aline de Jesus Gon çalves Charlise Fortunato Pedroso Adriana Oliveira Guilarde Geraldo Andrade de Oliveira Karla de Aleluia Batista Tags: Article Source Type: research
Big COVID-19 waves may be coming, new Omicron strains suggest
Nearly 3 years into the pandemic, SARS-CoV-2 faces a formidable challenge: finding new ways around the immunity humans have built up through vaccines and countless infections. Worrisome new data show it is up to the challenge. Several new and highly immune-evasive strains of the virus have caught scientists’ attention in recent weeks; one or more may well cause big, new COVID-19 waves this fall and winter.
“We can say with certainty that something is coming. Probably multiple things are coming,” says Cornelius Roemer, who studies viral evolution at the University of Basel. Whether they will also lead to many hos...
Source: ScienceNOW - September 27, 2022 Category: Science Source Type: news
Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
J Korean Med Sci. 2022 Feb 7;37(5):e32. doi: 10.3346/jkms.2022.37.e32.ABSTRACTDermatomyositis (DM) is one of the uncommon multi-organ idiopathic inflammatory myopathies that has been reported following the hepatitis B, Influenza, tetanus toxoid, H1N1, and BCG vaccines. However, an association with the coronavirus disease 2019 (COVID-19) vaccine is yet to be reported. In this case, we present the case of a 43-year-old Asian Indian female who was diagnosed with DM 10 days after receiving the second dosage of BNT162b2 mRNA COVID-19 vaccination, in the absence of any additional triggering factors. The diagnosis was established...
Source: Journal of Korean Medical Science - February 8, 2022 Category: Biomedical Science Authors: Wesam Gouda Anwar Albasri Faisal Alsaqabi Humoud Y Al Sabah Marwan Alkandari Hassan Abdelnaby Source Type: research
